Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	52.76	61.83	45.82	7.27	8.19	20.3
Short-Term Investments	81.54	78.57	14.4	-	4.93	-
Cash & Short-Term Investments	134.3	140.4	60.21	7.27	13.12	20.3
Cash Growth	152.20%	133.17%	728.67%	-44.62%	-35.38%	21.31%
Other Current Assets	0.46	0.06	0.08	0.07	0.05	0.22
Total Current Assets	134.76	140.46	60.29	7.33	13.17	20.52
Property, Plant & Equipment	0.22	0.25	-	0.01	0.06	-
Total Assets	134.98	140.72	60.29	7.35	13.23	20.52

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.92	2.64	2.25	1.76	3.13	1.58
Accrued Expenses	-	-	3	-	-	-
Current Portion of Leases	0.1	0.09	-	-	-	-
Total Current Liabilities	4.02	2.74	5.25	1.76	3.13	1.58
Long-Term Leases	0.11	0.15	-	-	0.01	-
Total Liabilities	4.12	2.89	5.25	1.76	3.14	1.58

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0.01	0.01
Additional Paid-In Capital	229.47	227.2	130.79	65.81	61.87	60.22
Retained Earnings	-98.72	-89.51	-75.79	-60.21	-51.8	-41.29
Comprehensive Income & Other	0.09	0.13	0.04	-0.01	0.01	-0
Total Common Equity	130.85	137.83	55.04	5.59	10.09	18.94
Shareholders' Equity	130.85	137.83	55.04	5.59	10.09	18.94
Total Liabilities & Equity	134.98	140.72	60.29	7.35	13.23	20.52

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.21	0.25	-	-	0.01	-
Net Cash (Debt)	134.09	140.15	60.21	7.27	13.11	20.3
Net Cash Growth	152.36%	132.77%	728.67%	-44.58%	-35.42%	21.31%
Net Cash Per Share	16.38	18.91	15.89	2.63	5.15	8.14
Filing Date Shares Outstanding	6.71	6.69	6.11	3.49	2.64	2.52
Total Common Shares Outstanding	6.71	6.69	6.1	2.98	2.59	2.52
Working Capital	130.75	137.73	55.04	5.58	10.04	18.94
Book Value Per Share	19.50	20.60	9.02	1.87	3.90	7.52
Tangible Book Value	130.85	137.83	55.04	5.59	10.09	18.94
Tangible Book Value Per Share	19.50	20.60	9.02	1.87	3.90	7.52

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error